Equities

Top Glove Corporation Bhd

Top Glove Corporation Bhd

Actions
Health CareMedical Equipment and Services
  • Price (MYR)0.81
  • Today's Change-0.02 / -2.41%
  • Shares traded15.11m
  • 1 Year change-21.36%
  • Beta--
Data delayed at least 15 minutes, as of Apr 19 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Top Glove Corporation Bhd. is a Malaysia-based manufacturer of gloves. The Company offers a product range, which includes a non-glove segment comprising condoms, face masks, dental dams, exercise bands and household products, fulfilling demand in both the healthcare and non-healthcare segment. Its gloves product categories include medical, surgical procedure, food and services, cleanroom, and safety and industrial. Its non gloves product categories include medical care, personal care, oral care, home care and industrial care. The Company operates in three principal geographical areas: Malaysia, Thailand and China. The Company has approximately 49 factories out of which 42 are in Malaysia, five are in Thailand, one is in China and one is in Vietnam. Its subsidiaries include Top Glove Sdn. Bhd., TG Medical Sdn. Bhd., Great Glove (Malaysia) Sdn. Bhd., Top Glove Engineering Sdn. Bhd. and TG Medical (U.S.A.), Inc.

  • Revenue in MYR (TTM)2.05bn
  • Net income in MYR-701.22m
  • Incorporated1998
  • Employees10.00k
  • Location
    Top Glove Corporation BhdLevel 21, Top Glove Tower, 16, PersiaranSHAH ALAM 40170MalaysiaMYS
  • Phone+60 333623098
  • Fax+60 333623860
  • Websitehttps://www.topglove.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Mani Inc815.71m203.56m5.93bn3.69k26.803.4222.127.2766.8266.82267.74523.800.49331.5212.007,156,310.0012.3111.4413.2112.3164.2263.2824.9626.117.32--0.00151.2519.954.0312.539.5624.1220.11
MicroPort Scientific Corp4.55bn-2.28bn6.17bn8.23k--1.70--1.36-2.05-2.054.083.230.23991.093.95904,540.30-16.38-11.85-27.68-18.0455.9762.96-68.28-44.431.26-5.820.5477--13.077.27-9.42------
Shandong Weigao Orthopaedic Devce Co Ltd848.20m74.22m6.20bn2.21k83.472.42--7.310.28110.28113.209.690.2310.63113.12580,791.502.0410.972.4813.6965.0877.338.8127.083.23--0.024317.90-30.551.17-79.36-19.11-4.31--
Shinva Medical Instrument Co Ltd6.62bn432.18m6.28bn8.21k14.101.28--0.94951.451.4521.8915.860.70132.235.551,219,621.004.744.6310.1510.7626.6024.226.766.120.7847--0.176615.917.87-0.534230.7895.70-5.9061.86
NAKANISHI INC.1.85bn706.36m6.35bn2.05k8.221.667.803.44267.42267.42698.691,327.050.49061.168.4329,132,440.0018.7712.7121.5514.0260.5261.4138.2626.602.05--0.093428.1222.6410.3183.1024.6511.2812.30
Nipro Corp17.88bn316.78m6.60bn38.77k23.060.83393.170.369253.9753.973,232.301,492.320.53491.863.3314,909,290.001.050.82751.611.2630.0330.301.971.540.8539--0.689560.4310.196.64-66.01-17.316.34-5.05
Beijing Wandong Medical Technolgy Co Ltd817.22m124.59m6.69bn1.06k53.702.15--8.190.26820.26821.766.700.2322.254.241,167,771.003.585.304.056.2141.4245.2115.4316.467.66--0.022835.8210.305.327.514.22-16.665.39
Ship Healthcare Holdings Inc19.12bn366.14m6.74bn8.05k18.271.5211.250.3524117.30117.306,087.681,408.211.6717.655.2376,835,940.003.153.686.586.8410.3810.551.882.361.18--0.288831.0511.266.10-0.89553.11-7.865.59
Top Glove Corporation Bhd2.05bn-701.22m6.81bn10.00k--1.15--3.32-0.0876-0.08760.2560.72340.2811--8.11128,154.80-9.0524.37-10.3931.04--43.76-32.2025.881.49-61.540.087470.79-59.49-11.77-510.18---4.47--
Shanghai Microport EP MedTech Co Ltd217.54m3.76m6.96bn577.001,850.296.25--31.980.01210.01210.69953.580.18211.177.24570,528.400.3147--0.3295--62.84--1.73--14.48--0.0153--26.46--85.17------
Shanghai MicroPort MedBot Group Co Ltd69.11m-668.79m7.12bn650.00--20.74--103.02-1.14-1.140.1180.58620.06230.37463.75174,066.60-60.96---86.19--14.05---978.59--0.8238-10.840.5427--384.16--11.20------
Fukuda Denshi Co Ltd4.34bn597.24m7.38bn3.38k9.901.108.271.70638.29638.294,642.155,726.010.69193.304.0841,521,290.009.517.5011.269.6053.6145.2713.759.963.31--0.010328.851.930.8796.5513.1410.8814.87
Angelalign Technology Inc975.24m35.33m7.74bn2.88k218.653.5187.527.940.34280.34289.4621.370.31945.3311.98553,810.401.055.761.297.5962.3864.333.3013.984.12--0.0188--16.2424.75-74.99-2.2020.54--
Data as of Apr 19 2024. Currency figures normalised to Top Glove Corporation Bhd's reporting currency: Malaysian Ringgit MYR

Institutional shareholders

12.65%Per cent of shares held by top holders
HolderShares% Held
Kumpulan Wang Persaraanas of 28 Nov 2023263.63m3.21%
Bank of Singapore Ltd.as of 28 Nov 2023225.20m2.74%
The Vanguard Group, Inc.as of 05 Apr 2024198.67m2.42%
Norges Bank Investment Managementas of 31 Dec 202378.73m0.96%
Principal Asset Management Bhd.as of 31 Dec 202374.22m0.90%
Hong Leong Asset Management Bhd.as of 30 Jun 202355.90m0.68%
BlackRock Fund Advisorsas of 04 Apr 202454.01m0.66%
Dimensional Fund Advisors LPas of 04 Apr 202448.16m0.59%
Bessemer Investment Management LLCas of 31 Jan 202421.46m0.26%
Kenanga Investors Bhd.as of 31 Dec 202318.37m0.22%
More ▼
Data from 30 Nov 2023 - 09 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.